5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 21.73▼ | 21.64▲ | 21.61▲ | 21.24▲ | 19.47▲ |
MA10 | 21.64▲ | 21.74▼ | 21.39▲ | 21.17▲ | 21.28▲ |
MA20 | 21.61▲ | 21.19▲ | 21.03▲ | 19.51▲ | 21.84▼ |
MA50 | 21.22▲ | 21.10▲ | 21.27▲ | 21.15▲ | 16.80▲ |
MA100 | 21.03▲ | 21.13▲ | 20.20▲ | 21.73▲ | 16.86▲ |
MA200 | 21.27▲ | 19.56▲ | 19.96▲ | 17.25▲ | 19.27▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.008▼ | 0.043▲ | 0.107▲ | 0.313▲ | -0.476▼ |
RSI | 56.699▲ | 58.357▲ | 58.754▲ | 57.294▲ | 54.055▲ |
STOCH | 76.476 | 41.674 | 64.839 | 64.175 | 42.336 |
WILL %R | -41.667 | -38.251 | -29.787 | -17.455▲ | -38.148 |
CCI | 88.667 | 48.264 | 77.173 | 83.015 | 14.621 |
Wednesday, April 30, 2025 05:00 AM
Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that company management ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 20.80 | 22.80 | 20.7976 | 21.75 | 138,646 |
30/04/25 | 20.79 | 21.05 | 20.00 | 20.885 | 59,429 |
29/04/25 | 20.83 | 21.44 | 20.53 | 20.975 | 72,279 |
28/04/25 | 21.66 | 21.66 | 20.65 | 21.03 | 149,367 |
25/04/25 | 21.37 | 22.06 | 20.95 | 21.54 | 50,806 |
24/04/25 | 21.90 | 22.03 | 20.4344 | 21.48 | 101,341 |
23/04/25 | 22.12 | 22.82 | 21.23 | 21.90 | 147,497 |
22/04/25 | 20.75 | 22.66 | 20.50 | 21.98 | 131,553 |
21/04/25 | 19.18 | 21.00 | 19.18 | 20.685 | 62,832 |
17/04/25 | 19.25 | 19.58 | 18.69 | 19.44 | 112,586 |
|
|
||||
|
|
||||
|
|